This mirrors our recently reported results in CML where by simultaneously modulating p53-driven apoptosis and MYC-driven differentiation we were able to selectively extinguish the leukaemic stem cell.33 No significant effect on colony size was obtained in any condition. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.